BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9766410)

  • 1. Randomized trial of magnesium administration to prevent hypocalcemia in infants of diabetic mothers.
    Mehta KC; Kalkwarf HJ; Mimouni F; Khoury J; Tsang RC
    J Perinatol; 1998; 18(5):352-6. PubMed ID: 9766410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early neonatal predictors of neonatal hypocalcemia in infants of diabetic mothers: an epidemiologic study.
    Mimouni F; Loughead J; Miodovnik M; Khoury J; Tsang RC
    Am J Perinatol; 1990 Jul; 7(3):203-6. PubMed ID: 2372324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses.
    McGuinness GA; Weinstein MM; Cruikshank DP; Pitkin RM
    Obstet Gynecol; 1980 Nov; 56(5):595-600. PubMed ID: 7432730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
    Riaz M; Porat R; Brodsky NL; Hurt H
    J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal surge in serum calcitonin concentrations: no contribution to neonatal hypocalcemia in infants of diabetic mothers.
    Mimouni F; Loughead JL; Tsang RC; Khoury J
    Pediatr Res; 1990 Nov; 28(5):493-5. PubMed ID: 2255574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia, hypomagnesemia, and hypocalcemia in infants of diabetic mothers.
    Mimouni F; Tsang RC; Hertzberg VS; Miodovnik M
    Am J Dis Child; 1986 Aug; 140(8):798-800. PubMed ID: 3728408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral spinal fluid and serum ionized magnesium and calcium levels in preeclamptic women during administration of magnesium sulfate.
    Apostol A; Apostol R; Ali E; Choi A; Ehsuni N; Hu B; Li L; Altura BT; Altura BM
    Fertil Steril; 2010 Jun; 94(1):276-82. PubMed ID: 19324346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment.
    Hallak M; Berry SM; Madincea F; Romero R; Evans MI; Cotton DB
    Obstet Gynecol; 1993 Feb; 81(2):185-8. PubMed ID: 8423946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible pathogenetic factors in hypocalcemia of low birth weight newborn infants (author's transl)].
    Romagnoli C; Pesaresi MA; CurrĂ² V; De Turris P; Zecca E; Torotrolo G
    Pediatr Med Chir; 1981; 3(2-3):171-6. PubMed ID: 7343911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased bone mineral content in infants of diabetic mothers.
    Mimouni F; Steichen JJ; Tsang RC; Hertzberg V; Miodovnik M
    Am J Perinatol; 1988 Oct; 5(4):339-43. PubMed ID: 3166641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal complications in infants born to diabetic mothers.
    Alam M; Raza SJ; Sherali AR; Akhtar AS
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):212-5. PubMed ID: 16542603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
    Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
    J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased amniotic fluid magnesium concentration in diabetic pregnancy.
    Mimouni F; Miodovnik M; Tsang RC; Callahan J; Shaul P
    Obstet Gynecol; 1987 Jan; 69(1):12-4. PubMed ID: 3796911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic risk factors in infants of diabetic mothers.
    Sarkar S; Hagstrom NJ; Ingardia CJ; Lerer T; Herson VC
    J Perinatol; 2005 Feb; 25(2):134-8. PubMed ID: 15526010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers.
    Banerjee S; Mimouni FB; Mehta R; Llanos A; Bainbridge R; Varada K; Sheffer G
    Magnes Res; 2003 Jun; 16(2):127-30. PubMed ID: 12892383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine.
    Koontz SL; Friedman SA; Schwartz ML
    Am J Obstet Gynecol; 2004 Jun; 190(6):1773-6. PubMed ID: 15284796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of magnesium in neonatal calcium homeostasis: effects of magnesium infusion on calciotropic hormones and calcium.
    Shaul PW; Mimouni F; Tsang RC; Specker BL
    Pediatr Res; 1987 Sep; 22(3):319-23. PubMed ID: 3658552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective controlled study of neonatal morbidities in infants born at 36 weeks or more gestation to Women with diet-controlled gestational diabetes (GDM-class Al).
    Sarkar S; Watman J; Seigel WM; Schaeffer HA
    J Perinatol; 2003; 23(3):223-8. PubMed ID: 12732860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial.
    Bhat MA; Charoo BA; Bhat JI; Ahmad SM; Ali SW; Mufti MU
    Pediatrics; 2009 May; 123(5):e764-9. PubMed ID: 19349375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.